HIA
ABBV icon

HFM Investment Advisors’s AbbVie ABBV Stock Holding History

HFM Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04K Sell
14
-22
-61% -$4.88K ﹤0.01% 188
2025
Q4 		$8.23K Buy
36
+1
+3% +$228 ﹤0.01% 137
2025
Q3 		$8.1K Hold
35
– – ﹤0.01% 90
2025
Q2 		$6.5K Buy
35
+20
+133% +$3.72K ﹤0.01% 107
2025
Q1 		$3.14K Buy
+15
New +$2.92K ﹤0.01% 124

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HFM Investment Advisors's ABBV Position: Q1 2026 in Review

HFM Investment Advisors reduced its AbbVie (ABBV) stake by 61% in Q1 2026, selling an estimated $4.88K and leaving 14 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #188.

HFM Investment Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.23K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • HFM Investment Advisors held 14 shares of AbbVie worth $3.04K as of Q1 2026.
  • HFM Investment Advisors sold 22 AbbVie shares in Q1 2026, an estimated $4.88K.
  • AbbVie made up ﹤0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #188 holding.
  • HFM Investment Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • HFM Investment Advisors's AbbVie position peaked at $8.23K in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.